financetom
Business
financetom
/
Business
/
Update: Boeing, Southwest Facing Regulatory Probe Over Loss of Engine Cover on Flight to Houston
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Boeing, Southwest Facing Regulatory Probe Over Loss of Engine Cover on Flight to Houston
Apr 8, 2024 6:18 AM

08:58 AM EDT, 04/08/2024 (MT Newswires) -- (Updates with Southwest ( LUV ) statement in fourth paragraph)

Boeing ( BA ) and Southwest Airlines ( LUV ) shares were down early Monday after the US aviation regulator launched a probe into an incident where a 737-800 jet operated by the airline suffered a structural failure over the weekend.

A Southwest ( LUV ) flight to Houston on Sunday was forced to return to Denver International airport after crew reported the plane's engine cowling fell off during takeoff and struck its wing flap. The Boeing 737-800 jet was towed to the gate, with no casualties or injuries reported.

The Federal Aviation Administration said it will look into the matter. Shares of Southwest ( LUV ) decreased 1.9% in premarket trading while Boeing ( BA ) fell 1.1%.

In an emailed response to MT Newswires, Boeing ( BA ) referred to Southwest ( LUV ) for additional information about the plane and the company's fleet operations. Southwest ( LUV ) said in an email that the company's maintenance team is reviewing the aircraft. "The investigation is still underway, and we do not have anything additional to add at this time," a spokesperson said. The plane was certified in 2015, according to an FAA public record.

The incident is the latest facing Boeing ( BA ) in recent months. In January, one of the aircraft manufacturer's 737 Max 9 planes operated by Alaska Air (ALK) saw a window and a chunk of fuselage blow out shortly after takeoff, prompting the FAA to ground the model for several weeks and open an investigation.

Alaska Airlines said last week that it received $160 million from Boeing ( BA ) for the financial impact of the grounding of the carrier's 737 Max 9 fleet, and expects additional compensation from the jet maker. In March, the FAA revealed plans to investigate three incidents involving 737 planes being flown domestically by United Airlines (UAL) and American Airlines (AAL).

Boeing ( BA ) made senior leadership changes last month, including the departure of Dave Calhoun as chief executive at the end of this year, as part of attempts to regain its footing. Steve Mollenkopf, who is set to take over from Larry Kellner as board chair at Boeing's ( BA ) upcoming annual shareholders meeting, will lead the company's process to find a new CEO.

The manufacturer also refrained from issuing full-year financial guidance when it reported its fourth-quarter results at the end of January, as it outlined plans to improve the quality of its 737 Max planes.

Price: 181.28, Change: -1.86, Percent Change: -1.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-US prosecutors recommend DOJ criminally charge Boeing as deadline looms
Exclusive-US prosecutors recommend DOJ criminally charge Boeing as deadline looms
Jun 24, 2024
WASHINGTON (Reuters) - U.S. prosecutors are recommending to senior Justice Department officials that criminal charges be brought against Boeing after finding the planemaker violated a settlement related to two fatal crashes, two people familiar with the matter told Reuters. The Justice Department must decide by July 7 whether to prosecute Boeing. The recommendation of prosecutors handling the case has not...
Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators
Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators
Jun 24, 2024
04:36 AM EDT, 06/24/2024 (MT Newswires) -- Takeda (TAK) said Monday that its drug Livtencity has been approved by the Japan's Ministry of Health, Labour and Welfare for the treatment of cytomegalovirus disease that is resistant to existing therapies in patients with transplanted organs. The drug, also known as maribavir, was approved following a phase 3 trial involving 352 patients...
argenx Says FDA Approved Vyvgart Hytrulo for Treatment of Neuromuscular Disorder
argenx Says FDA Approved Vyvgart Hytrulo for Treatment of Neuromuscular Disorder
Jun 24, 2024
04:46 AM EDT, 06/24/2024 (MT Newswires) -- argenx (ARGX) said late Friday the US Food and Drug Administration has approved Vyvgart Hytrulo for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder that causes a range of disabling mobility and sensory issues. The approval is based on a clinical trial in which 69% of patients treated...
New York Community Bancorp Files Mixed Securities Shelf
New York Community Bancorp Files Mixed Securities Shelf
Jun 24, 2024
04:33 AM EDT, 06/24/2024 (MT Newswires) -- New York Community Bancorp ( NYCB/PU ) filed a registration statement Friday for the potential sale of up to 840 million of its common shares by selling stockholders and 315,000 warrants. The shares comprise of 332.9 million of common stock, 192.0 million of series B convertible preferred stock and 315.0 million of stock...
Copyright 2023-2026 - www.financetom.com All Rights Reserved